China is expected to become even more central to our business in the coming years, because it sparks additional opportunities for cooperation and because it is…
In Conversation
[Allergan] is at once a pharma company, a medical device company, a cosmetics/aesthetics company and a digital company
2018 was a milestone year for Illumina China because we received NMPA approval of our diagnostic Next Generation Sequencing machine, MiSeqDx System – our first Illumina-branded…
In terms of the healthcare market, China is actually very similar to Europe, where the healthcare budget management deeply depends on each province
Speed is the largest [cultural] difference I have witnessed. A Chinese customer who buys a product is used to getting an answer immediately
In 2014, my first angel investor actually told me, "91 percent of these kinds of research programs fail. I am not investing in SIMR because I…
Good investors should look into the specific unmet medical needs companies are trying to address and how they are addressing them rather than simply focusing on…
Half of the top 200 drugs in the world are inspired by plants
Positive government policies and positive industry development have in turn contributed to positive growth for Medidata China
Laekna is committed to remaining a highly professional team and we keep our promises. To date, whatever we promised, we have delivered.
Our people here dare to accept challenges and always try different things
Speed is of critical importance, particularly in the competitive field of immuno-oncology